| 470 |
Deposition of energy leads to abnormal vascular remodeling |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2069: Occurrence, Abnormal Vascular Remodeling
|
WPHA/WNT Endorsed |
1.89 |
| 471 |
Neuron defect induced early behavioral change |
Woo-Keun Kim |
BY-SA |
2195: Increase, CNS Neural cell death
|
7 AOs
|
|
|
| 472 |
DNA adduct formation leading to kidney failure |
Manoe Janssen |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
759: Increased, Kidney Failure
|
|
|
| 473 |
Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin |
Danielle Beaton |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 476 |
Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity |
Yue Zhang |
BY-SA |
3 MIEs
|
4 AOs
|
|
|
| 477 |
Androgen receptor (AR) antagonism leading to hypospadias in male (mammalian) offspring |
Terje Svingen |
BY-SA |
26: Antagonism, Androgen receptor
|
2082: Hypospadias, increased
|
|
|
| 521 |
Essential element imbalance leads to reproductive failure via oxidative stress |
Travis Karschnik |
BY-SA |
2205: Increased, essential element imbalance
|
2147: Decreased, Viable Offspring
|
|
|
| 524 |
Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals |
Antonio Fernandez Dumont |
BY-SA |
3 MIEs
|
2257: Celiac disease
|
Under Review |
1.98 |
| 526 |
Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis |
John Frisch |
BY-SA |
None
|
1758: Impaired, Spermatogenesis
|
|
|
| 527 |
Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased |
John Frisch |
BY-SA |
None
|
2082: Hypospadias, increased
|
|
|
| 494 |
AhR activation leading to liver fibrosis |
Xavier COUMOUL |
BY-SA |
18: Activation, AhR
|
344: Increase, Liver fibrosis
|
|
|
| 495 |
Androgen receptor activation leading to prostate cancer |
Jianxiang Li |
BY-SA |
25: Agonism, Androgen receptor
|
2135: Prostate cancer
|
|
|
| 496 |
Androgen receptor agonism leading to reproduction dysfunction (in zebrafish) |
Hongling Liu |
BY-SA |
25: Agonism, Androgen receptor
|
442: Decreased, Population trajectory
|
|
|
| 497 |
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome |
Min Ji Kim |
BY-SA |
2126: Estrogen receptor alpha inactivation
|
2 AOs
|
|
|
| 499 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 500 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 503 |
Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation |
Barbara Viviani |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2154: Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
|
Under Review |
1.100 |
| 504 |
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Martina Panzarea |
BY-SA |
2155: Inhibition of Sulfotransferase E1 (SULT1E1)
|
1065: Activation, estrogen receptor alpha
|
|
|
| 596 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell injury/death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 605 |
Thyroid Peroxidase Inhibition Leading to Reduced, Swimming Performance via Hypomyelination |
Ki-Tae Kim |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
|
|
| 603 |
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell cycle disruption |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 602 |
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 601 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and reduced cell proliferation |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 600 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and reduced cell growth |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|
| 599 |
Excessive reactive oxygen species leading to growth inhibition via fatty acid oxidation and cell injury/death |
You Song |
BY-SA |
1115: Increase, Reactive oxygen species
|
1521: Decrease, Growth
|
|
|